Andreas Kluth, Phd Email & Phone Number

Responsible for managing the company's operational, scientific, clinical, technological, and research operations; Leading a cross-functional team of GMP experts, GCP clinical trial managers, regulatory affairs specialists and scientists to develop and establish ATMPs and antibody-based therapies 'in-house' for immunomodulation or anti-cancer treatment from 'bench to bedside'. Communication and networking with KoL´s.

Release of Drug Product and Drug Substances (ATMP), Method Validation and Development according to Ph.Eur requirements, PQR, CAPA, CC and Deviation Management, Qualification of Equipment, IQ, OQ, PQ, Release and Quality Control of Raw Materials, preparation and managing of agency inspections, main responsible for submission of §13 AMG documents and agency communication, self-inspections

Development and Validation of a GMP manufacturing process for ABCB5+ Mesenchymal Stem Cells and Limbal Stem Cells, Set up of a high-level Clean Room facility (class A in B) and GMP system, preparation and submission of §13 AMG documents and main responsible for agency communication

Hamburg, De

Investigation of p53-mediated cell differentiation during early development by post-transcriptional changes in tumor stem cells and embryonic stem cells

Eching, De

Wilmington, Massachusetts, Us

GLP/GMP-certified S3-laboratory for Virology and Prion analytics

Leverkusen, North Rhine-Westphalia, De

Dr. Rerum Naturalium, P53-Mediated Mechanism Of Cell Differentiation And Epigenetic Regulation Of Stem Cells

Master Of Science - Ms, Molecular Biology – Biomedicine

Bachelor Of Science - Bs, Molecular Biology – Biomedicine

Biological Technical Assistant